1. Home
  2. ZLAB vs QS Comparison

ZLAB vs QS Comparison

Compare ZLAB & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • QS
  • Stock Information
  • Founded
  • ZLAB 2013
  • QS 2010
  • Country
  • ZLAB China
  • QS United States
  • Employees
  • ZLAB N/A
  • QS N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • QS Auto Parts:O.E.M.
  • Sector
  • ZLAB Health Care
  • QS Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • QS Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • QS 4.5B
  • IPO Year
  • ZLAB 2017
  • QS N/A
  • Fundamental
  • Price
  • ZLAB $33.34
  • QS $7.74
  • Analyst Decision
  • ZLAB Buy
  • QS Sell
  • Analyst Count
  • ZLAB 6
  • QS 7
  • Target Price
  • ZLAB $57.22
  • QS $5.90
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • QS 21.0M
  • Earning Date
  • ZLAB 08-07-2025
  • QS 10-22-2025
  • Dividend Yield
  • ZLAB N/A
  • QS N/A
  • EPS Growth
  • ZLAB N/A
  • QS N/A
  • EPS
  • ZLAB N/A
  • QS N/A
  • Revenue
  • ZLAB $427,799,000.00
  • QS N/A
  • Revenue This Year
  • ZLAB $42.62
  • QS N/A
  • Revenue Next Year
  • ZLAB $55.12
  • QS N/A
  • P/E Ratio
  • ZLAB N/A
  • QS N/A
  • Revenue Growth
  • ZLAB 32.56
  • QS N/A
  • 52 Week Low
  • ZLAB $18.91
  • QS $3.40
  • 52 Week High
  • ZLAB $44.34
  • QS $15.03
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • QS 41.01
  • Support Level
  • ZLAB $31.79
  • QS $8.00
  • Resistance Level
  • ZLAB $35.45
  • QS $8.56
  • Average True Range (ATR)
  • ZLAB 1.00
  • QS 0.47
  • MACD
  • ZLAB -0.22
  • QS -0.09
  • Stochastic Oscillator
  • ZLAB 31.12
  • QS 8.72

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About QS QuantumScape Corporation

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.

Share on Social Networks: